Cardiovascular risk in women with premature ovarian insufficiency compared to premenopausal women at middle age

Journal of Clinical Endocrinology and Metabolism

Volumn 101, Issue 9, 2016, Pages 3306-3315

  Daan, Nadine M P ^a   Muka, Taulant ^b   Koster, Maria P H ^a   Van Lennep, Jaenine E Roeters ^b   Lambalk, Cornelis B ^c   Laven, Joop S E ^b   Fauser, Clemens G K M ^a   Meun, Cindy ^b   De Rijke, Yolanda B ^b   Boersma, Eric ^d   Franco, Oscar H ^b   Kavousi, Maryam ^b   Fauser, Bart C J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANDROSTENEDIONE; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; ESTRADIOL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL; URIC ACID; BIOLOGICAL MARKER;

ADULT; ANDROGEN BLOOD LEVEL; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; ESTRADIOL BLOOD LEVEL; FEMALE; FREE THYROXINE INDEX; GLOBULIN BLOOD LEVEL; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MIDDLE AGED; MULTICENTER STUDY; PR INTERVAL; PREMATURE OVARIAN FAILURE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QRS INTERVAL; QT INTERVAL; RR INTERVAL; SUBCLINICAL ATHEROSCLEROSIS; SYSTOLIC BLOOD PRESSURE; TESTOSTERONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; UNIVERSITY HOSPITAL; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE; AGED; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; COMPLICATION; EARLY MENOPAUSE; FOLLOW UP; MALE; METABOLIC SYNDROME X; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; BIOMARKERS; CARDIOVASCULAR DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MENOPAUSE, PREMATURE; METABOLIC SYNDROME X; MIDDLE AGED; PRIMARY OVARIAN INSUFFICIENCY; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84988918797     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2016-1141     Document Type: Article

References (66)

1. Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29-e322
2. van der Schouw YT, van der Graaf Y, Steyerberg EW, Eijkemans JC, Banga JD. Age at menopause as a risk factor for cardiovascular mortality. Lancet. 1996;347(9003):714-718
3. Ossewaarde ME, Bots ML, Verbeek AL, et al. Age at menopause, cause-specific mortality and total life expectancy. Epidemiology. 2005;16(4):556-562
4. Wellons M, Ouyang P, Schreiner PJ, Herrington DM, Vaidya D. Early menopause predicts future coronary heart disease and stroke: The Multi-Ethnic Study of Atherosclerosis. Menopause. 2012; 19(10):1081-1087
5. Ebong IA, Watson KE, Goff DC Jr, et al. Age at menopause and incident heart failure: The multi-ethnic study of atherosclerosis. Menopause. 2014;21(6):585-591
6. Atsma F, Bartelink ML, Grobbee DE, van der Schouw YT. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause. 2006; 13(2):265-279
7. Tunstall-Pedoe H. Myth and paradox of coronary risk and the menopause. Lancet. 1998;351(9113):1425-1427
8. Matthews KA, Crawford SL, Chae CU, et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? JAmColl Cardiol. 2009; 54(25):2366-2373
9. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol. 1986;67(4):604-606
10. European Society ofHumanReproduction and Embryology. Guideline on the management of premature ovarian insufficiency. Accessed June 2016. https://www.eshre.eu/Guidelines-and-Legal/ Guidelines/Management-of-premature-ovarian-insufficiency.aspx
11. Roeters Lennep JE, Heida KY, Bots ML, et al. Cardiovascular disease risk in women with premature ovarian insufficiency: a systematic review and meta-analysis. Eur J Prev Cardiol. 2016;23(2): 178-186
12. Tao XY, Zuo AZ, Wang JQ, Tao FB. Effect of primary ovarian insufficiency and early natural menopause on mortality: a metaanalysis. Climacteric. 2016;19(1):27-36
13. Knauff EA, Westerveld HE, Goverde AJ, et al. Lipid profile of women with premature ovarian failure. Menopause. 2008;15(5): 919-923
14. Janse F, Tanahatoe SJ, Eijkemans MJ, Fauser BC. Testosterone concentrations, using different assays, in different types of ovarian insufficiency: a systematic review and meta-analysis. Hum Reprod Update. 2012;18(4):405-419
15. Daan NM, Jaspers L, Koster MP, et al. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features. Hum Reprod. 2015;30(10):2376-2386
16. Bernini GP, Moretti A, Sgró M, et al. Influence of endogenous androgens on carotid wall in postmenopausal women. Menopause. 2001;8(1):43-50
17. Ouyang P, Vaidya D, Dobs A, et al. Sex hormone levels and subclinical atherosclerosis in postmenopausal women: The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis. 2009;204(1):255-261
18. Janse F, Knauff EA, Niermeijer MF, et al. Similar phenotype characteristics comparing familial and sporadic premature ovarian failure. Menopause. 2010;17(4):758-765
19. Hofman A, Darwish Murad S, van Duijn CM, et al. The Rotterdam Study: 2014 objectives and design update. Eur J Epidemiol. 2013; 28(11):889-926
20. Leening MJ, Kavousi M, Heeringa J, et al. Methods of data collection and definitions of cardiac outcomes in the Rotterdam Study. Eur J Epidemiol. 2012;27(3):173-185
21. Bots ML, Grobbee DE, Hofman A, Witteman JC. Common carotid intima-media thickness and risk of acute myocardial infarction: the role of lumen diameter. Stroke. 2005;36(4):762-767
22. Kavousi M, Elias-Smale S, Rutten JH, et al. Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study. Ann Intern Med. 2012;156(6):438-444
23. Bos S, Duvekot MH, Touw-Blommesteijn AC, et al. Lipoprotein (a) levels are not associated with carotid plaques and carotid intima media thickness in statin-treated patients with familial hypercholesterolemia. Atherosclerosis. 2015;242(1):226-229
24. Vanoli D, Wiklund U, Lindqvist P, Henein M, Näslund U. Successful novice's training in obtaining accurate assessment of carotidIMT using an automated ultrasound system. Eur Heart J Cardiovasc Imaging. 2014;15(6):637-642
25. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499-502
26. Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem. 1992; 38(10):1933-1953
27. van Driel LM, Eijkemans MJ, Jonge R, et al. Body mass index is an important determinant of methylation biomarkers in women of reproductive ages. J Nutr. 2009;139(12):2315-2321
28. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-1645
29. Chambless LE, Heiss G, Folsom AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: The Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol. 1997;146(6):483-494
30. Lorenz MW, von Kegler S, Steinmetz H, Markus HS, Sitzer M. Carotid intima-media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke. 2006;37(1):87-92
31. Bechlioulis A, Kalantaridou SN, Naka KK, et al. Endothelial function, but not carotid intima-media thickness, is affected early in menopause and is associated with severity of hot flushes. J Clin Endocrinol Metab. 2010;95(3):1199-1206
32. Canoy D, Cairns BJ, Balkwill A, et al. Coronary heart disease incidence in women by waist circumference within categories of body mass index. Eur J Prev Cardiol. 2013;20(5):759-762
33. Rexrode KM, Carey VJ, Hennekens CH, et al. Abdominal adiposity and coronary heart disease in women. JAMA. 1998;280(21):1843-1848
34. Pischon T, Boeing H, Hoffmann K, et al. General and abdominal adiposity and risk of death in Europe.NEngl J Med. 2008;359(20): 2105-2120
35. Després JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis. 1990;10(4):497-511
36. Guthrie JR, Dennerstein L, Taffe Lehert P, Burger HG. The menopausal transition: a 9-year prospective population-based study. The Melbourne Women's Midlife Health Project. Climacteric. 2004; 7(4):375-389
37. Abdulnour J, Doucet E, Brochu M, et al. The effect of the menopausal transition on body composition and cardiometabolic risk factors: a Montreal-Ottawa New Emerging Team Group Study. Menopause. 2012;19(7):760-767
38. Hocking S, Samocha-Bonet D, Milner KL, Greenfield JR, Chisholm DJ. Adiposity and insulin resistance in humans: the role of the different tissue and cellular lipid depots. Endocr Rev. 2013;34(4):463-500
39. Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375(9709):132-140
40. Verit FF, Keskin S, Omer B, Yalcinkaya S, Sakar N. Is there any relationship between cardiovascular risk markers and youngwomen with diminished ovarian reserve? Gynecol Endocrinol. 2014; 30(10):697-700
41. Laughlin GA, Goodell V, Barrett-Connor E. Extremes of endogenous testosterone are associated with increased risk of incident coronary events in older women. J Clin Endocrinol Metab. 2010;95(2): 740-747
42. Chen Y, Zeleniuch-Jacquotte A, Arslan AA, et al. Endogenous hormones and coronary heart disease in postmenopausal women. Atherosclerosis. 2011;216(2):414-419
43. Barrett-Connor E, Young R, Notelovitz M, et al. A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women. Effects on bone mineral density, symptoms and lipid profiles. J Reprod Med. 1999;44(12): 1012-1020
44. Barrett-Connor E, Goodman-Gruen D. Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women. BMJ. 1995;311(7014):1193-1196
45. Khatibi A, Agardh CD, Shakir YA, et al. Could androgens protect middle-aged women from cardiovascular events? A populationbased study of Swedish women: the Women's Health in the Lund Area (WHILA) Study. Climacteric. 2007;10(5):386-392
46. Peters SA, Huxley RR, Woodward M. Comparison of the sex-specific associations between systolic blood pressure and the risk of cardiovascular disease: a systematic review and meta-analysis of 124 cohort studies, including 1.2 million individuals. Stroke. 2013; 44(9):2394-2401
47. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Hypertension. 2003;42(5):1050-1065
48. Culleton BF, LarsonMG,Wilson PW, Evans JC, Parfrey PS, Levy D. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int. 1999;56(6):2214-2219
49. Garg AX, Clark WF, Haynes RB, House AA. Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I. Kidney Int. 2002;61(4):1486-1494
50. Muntner P, He J, Hamm L, Loria C, Whelton PK. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol. 2002;13(3):745-753
51. Manjunath G, Tighiouart H, Ibrahim H, et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol. 2003;41(1):47-55
52. Sutton-Tyrrell K, Lassila HC, Meilahn E, Bunker C, Matthews KA, Kuller LH. Carotid atherosclerosis in premenopausal and postmenopausal women and its association with risk factors measured after menopause. Stroke. 1998;29(6):1116-1121
53. Muscelli E, Kozàkovà M, Flyvbjerg A, et al. The effect of menopause on carotid artery remodeling, insulin sensitivity, and plasma adiponectin in healthy women.AmJ Hypertens. 2009;22(4):364-370
54. Wildman RP, Schott LL, Brockwell S, Kuller LH, Sutton-Tyrrell K. A dietary and exercise intervention slows menopause-associated progression of subclinical atherosclerosis as measured by intimamedia thickness of the carotid arteries. J Am Coll Cardiol. 2004; 44(3):579-585
55. Trémollieres FA, Bauvin E, Cigagna F, et al. Association of cardiovascular risk factors with intima-media thickness of the carotid arteries in early postmenopausal women. Menopause. 2004;11(3): 323-330
56. Maturana MA, Franz RF, Metzdorf M, da Silva TR, Spritzer PM. Subclinical cardiovascular disease in postmenopausal women with low/medium cardiovascular risk by the Framingham risk score. Maturitas. 2015;81(2):311-316
57. El Khoudary SR, Wildman RP, Matthews K, Thurston RC, Bromberger JT, Sutton-Tyrrell K. Progression rates of carotid intimamedia thickness and adventitial diameter during the menopausal transition. Menopause. 2013;20(1):8-14
58. Kalantaridou SN, Naka KK, Papanikolaou E, et al. Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy. J Clin Endocrinol Metab. 2004;89(8):3907-3913
59. Yorgun H, Tokgözolu L, Canpolat U, et al. The cardiovascular effects of premature ovarian failure. Int J Cardiol. 2013;168(1): 506-510
60. Leening MJ, Ferket BS, Steyerberg EW, et al. Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study. BMJ. 2014;349:g5992
61. Mack WJ, Slater CC, Xiang M, Shoupe D, Lobo RA, Hodis HN. Elevated subclinical atherosclerosis associated with oophorectomy is related to time since menopause rather than type of menopause. Fertil Steril. 2004;82(2):391-397
62. Nahas EA, Nahas-Neto J, Orsatti CL, Sobreira ML, Tardivo AP, Witkin SS. Evaluation of clinical and inflammatory markers of subclinical carotid atherosclerosis in postmenopausal women. Menopause. 2014;21(9):982-989
63. HodisHN,MackWJ, HendersonVW,et al. Vascular effects of early versus late postmenopausal treatment with estradiol.NEngl J Med. 2016;374(13):1221-1231
64. Matthews KA, Kuller LH, Sutton-Tyrrell K, Chang YF. Changes in cardiovascular risk factors during the perimenopause and postmenopause and carotid artery atherosclerosis in healthy women. Stroke. 2001;32(5):1104-1111
65. Kuh D, Langenberg C, Hardy R, et al. Cardiovascular risk at age 53 years in relation to the menopause transition and use of hormone replacement therapy: a prospective British Birth Cohort Study. BJOG. 2005;112(4):476-485
66. Collins P, Rosano G, Casey C, et al. Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists. Eur Heart J. 2007;28(16): 2028-2040